Skip to main content
Log in

Acute amiodarone-induced lung toxicity

  • Brief Report
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

Abstract

Objective: To investigate any relationship between the pathological features of amiodarone-induced pulmonary toxicity (APT) and clinical use of amiodarone in patients dying from acute respiratory distress syndrome (ARDS).

Design: Retrospective study. Review of clinical and pathological findings of patients dying from ARDS.

Setting: Intensive Care Unit (ICU) and Pathology Department of University hospital.

Subjects: Ten patients with clinical diagnosis of ARDS, who died in ICU and underwent post mortem examination.

Interventions: Case note review of clinical details; independent review of histological specimens.

Measurement and results: Over a 3-year period, ten patients underwent post mortem examination, of whom seven had received amiodarone. Three patients who received longer than 48 h of amiodarone had histological changes of widespread lipoid pneumonia, a recognised pattern of APT.

Conclusions: Acute amiodarone pulmonary toxicity is a definite pathological entity in ICU patients. High oxygen concentrations may be a risk factor, while pre-existing pathology, e. g. ARDS, may mask its development. Amiodarone should be used with caution in this group of patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Sanai L, Armstrong IR, Grant IS (1993) Supraventricular tachydysrhythmias in the critically ill. Br J Intensive Care 3: 358–364

    Google Scholar 

  2. Holt AW (1989) Haemodynamic responses to amiodarone in critically ill patients receiving catecholamine infusions. Crit Care Med 17:1270–1276

    PubMed  CAS  Google Scholar 

  3. Lahini R, Tognoni G, Kates RE (1984) Clinical pharmacokinetics of amiodarone. Clin Pharmacokinetics 9:136–156

    Article  Google Scholar 

  4. Martin WJ, Rosenow EC (1988) Amiodarone pulmonary toxicity; recognition and pathogenesis. Chest 93:1067–1075

    Article  PubMed  Google Scholar 

  5. Greenspon AJ, Kidwell GA, Hurley W, Mannion J (1991) Amiodarone-related respiratory distress syndrome. Circulation 84: 407–415

    Google Scholar 

  6. Kay GN, Epstein AE, Kiridin JK, Dietheirn AG, Graybar G, Plumb VJ (1988) Fatal postoperative amiodarone pulmonary toxicity. Am J Cardiol 62: 490–492

    Article  PubMed  CAS  Google Scholar 

  7. Duke PK, Ramsay MAE, Hendon JC, Swgert T, Cook AO (1991) Acute oxygen-induced amiodarone pulmonary toxicity after general anesthesia (Abstract). Anesthesiology 75: A228

  8. Van Mieghem W, Coolen L, Malysse I, Lacquet LM, Deneffe GJD, Demedts MGP (1994) Amiodarone and the development of ARDS after lung surgery. Chest 105:1642–1645

    Article  PubMed  Google Scholar 

  9. Zitnik RJ (1996) Drug-induced lung disease: anti-arrhythmic agents. J Respir Dis 17: 254–269

    Google Scholar 

  10. Dake M, Madison JM, Montgomery CK, et al. (1985) Electron microscopic demonstration of lysosomal inclusion bodies in lung, liver, lymph nodes and blood leukocytes of patients with amiodarone pulmonary toxicity. Am J Med 78: 506–511

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Donaldson, L., Grant, I.S., Naysmith, M.R. et al. Acute amiodarone-induced lung toxicity. Intensive Care Med 24, 626–630 (1998). https://doi.org/10.1007/s001340050627

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s001340050627

Key words

Navigation